Literature DB >> 18288735

Successful use of the Heartrail III catheter as a stent delivery catheter following failure of conventional techniques.

M A Mamas1, F Fath-Ordoubadi, D Fraser.   

Abstract

The Terumo "five in six" system involves insertion of an extra length, 5 Fr Terumo guide catheter (Heartrail, Terumo) into a standard 6 Fr guide catheter so that the tip protrudes beyond the 6 Fr guide. This system increases backup support and has been used successfully to advance balloon catheters across chronic total occlusions. We describe the use of this system to facilitate extra deep intubation, enabling distal stent delivery beyond proximal points of obstruction that had been unsuccessful using more conventional techniques. (c) 2008 Wiley-Liss, Inc.

Mesh:

Year:  2008        PMID: 18288735     DOI: 10.1002/ccd.21395

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

1.  Recanalisation of coronary chronic total occlusions with new techniques including the retrograde approach via collaterals.

Authors:  A Bufe; G Haltern; W Dinh; J Wolfertz; H Schleiting; H Guelker
Journal:  Neth Heart J       Date:  2011-04       Impact factor: 2.380

2.  The "Five-in-Seven" Guiding Technique to Overcome Proximal Coronary Tortuosity During Primary Percutaneous Coronary Intervention.

Authors:  Sung-Yeon Cho; Keon-Woong Moon; Ji-Hoon Kim; Ki-Dong Yoo; Su-Sung Oh; Jin-Hee No; Chung-Hwa Park; Chul-Min Kim
Journal:  Korean Circ J       Date:  2010-08-31       Impact factor: 3.243

3.  The Safety and Efficacy of Guidezilla Catheter (Mother-in-Child Catheter) in Complex Coronary Interventions: An Observational Study.

Authors:  Prakash Kumar; Puneet Aggarwal; Santosh Kumar Sinha; Dibbendu Khanra; Mahmodullah Razi; Awdesh Kumar Sharma; Ramesh Thakur; Umeshwar Pandey; Vinay Krishna
Journal:  Cardiol Res       Date:  2019-11-24

4.  Early clinical experience with Guidezilla for transradial interventions in China.

Authors:  Min Ma; Kai-Yue Diao; Xiao-Jing Liu; Yong He
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.